Plasma Fractionation Market Size 2022-2027 | Global Industry Forecast, Share, Trends and Growth

Plasma Fractionation Market Size 2022-2027 | Global Industry Forecast, Share, Trends and Growth

“Plasma Fractionation Market Size”
The global plasma fractionation market size reached US$ 22.37 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 33.11 Billion by 2027 exhibiting a growth rate (CAGR) of 6.30% during 2022-2027

Plasma Fractionation Market Overview

The latest research study “Plasma Fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global plasma fractionation market size reached US$ 22.37 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 33.11 Billion by 2027 exhibiting a growth rate (CAGR) of 6.30% during 2022-2027.

Plasma fractionation represents the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or fractions by using numerous mechanical separation methods, such as depth filtration, centrifugation, precipitation, chromatography, etc. Presently, several advanced fractionation processes use alcohol concentrations, temperature, pH, etc., to extract specific therapeutic proteins. Furthermore, the introduction of in-process viral reduction treatments and increasing technological complexities have resulted in the development of new protein therapeutics as well as improved product purity and quality.

Covid-19 Impact Analysis:


We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a free sample brochure:

Plasma Fractionation Market Trends and Drivers: 

The growing prevalence of congenital deficiencies, blood infections, immunologic and autoimmune disorders, etc., is primarily driving the plasma fractionation market. Additionally, the escalating demand for this processing with additional safety features, on account of the implementation of various stringent regulations and standard settings by government bodies across countries for quality assurance of biological products, is also catalyzing the market growth.

Besides this, the rising investments in plasma production technology to improve efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins are acting as significant growth-inducing factors. Moreover, the widespread adoption of affordable viral inactivation processes that allow the utilization of local plasma resources safely is positively influencing the global market.

Apart from this, the inflating need for improving yield and maintaining process economics is anticipated to fuel the plasma fractionation market over the forecasted period.


Plasma Fractionation Market Report Scope

Report Coverage


Market size value in 2021

US$ 22.37 Billion

Market forecast in 2027

US$ 33.11 Billion

Growth Rate

CAGR of 6.30% from 2022 to 2027

Base year for estimation


Historical data


Forecast period


Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, Sector, Application and End user

Regional scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Key companies profiled

ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization preview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.


Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX  

Breakup by Sector:

  • Private Sector
  • Public Sector  

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications  

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

By Geography:

    • North America: (United States, Canada)
    • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
    • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
    • Latin America: (Brazil, Mexico, Others)
    • Middle East and Africa


Click here to view detailed information with table of content:

List of Major Key Players:

The major players in the market are

  • ADMA Biologics (NASDAQ: ADMA) 
  • Bio Products Laboratory Ltd.
  • Boccard
  • Grifols (NASDAQ: GRFS
  • S.A. (NYSE: SA)
  • Hemarus Therapeutics Limited
  • Intas Pharmaceuticals Limited
  • LFB S.A.
  • Merck Group (OTCMKTS: MKKGY)
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • SK Plasma Co. Ltd.
  • Virchow Biotech Private Limited.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Industry Research Reports:

Medical Disposables Market Size:

Insomnia Market Forecast:

Genotyping Market Share:

Dental Consumables Market Report:

Cancer Biomarkers Market Analysis:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States